secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIEMED HEALTHCARE, INC. (VMD)
CIK:        0001729149
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0001729149-26-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viemed posts record FY2025 revenue $270.3M; net income +33%; guides FY2026 rev $310-320M
--------------------------------------------------------------------------------

- Q4 revenue $76.2M (record, +26% YoY); FY revenue $270.3M (record, +21% YoY).
- FY2025 net income $14.9M ($0.37 diluted EPS), +33% YoY; adjusted EBITDA record $61.4M.
- FY2025 operating cash flow $51.9M; free cash flow $28.1M (more than doubled YoY).
- 2026 guidance: revenue $310-320M, adjusted EBITDA $65-69M, capex 10-11.5% of revenue.
- Board authorized share repurchase of up to 1,930,131 shares (~5% outstanding) through March 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729149/000172914926000008/0001729149-26-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729149/000172914926000008/vmd-20260304.htm
  HTML page:      https://secwatch.observer/filing/0001729149-26-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer